Registered Kenya · PPB

LAXTON TABLETS

SENNA TABLETS

CTD2538 7.5 MG GENERIC/BIOSIMILARS

What it does

Senna is a natural laxative used to relieve constipation.

Commonly used for: constipation, occasional constipation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
CTD2538
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
SENNA TABLETS
Dosage form
7.5 MG
Strength
-
Pack size
N/A
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Sai Pharmaceuticals
Country of origin
FOREIGN
Manufacturer location
Whitefield Edge, Junction of James Gichuru Road and Olengurone Road Lavington Nairobi KE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:47:08 · updated 2026-07-26 11:37:36

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Senna is a natural laxative used to relieve constipation.

What it treats

  • constipation
  • occasional constipation

How it works

Senna works by stimulating the muscles in the bowel, helping to move stool through the intestines.

Who it's for

Senna is suitable for adults and children who need relief from constipation.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Senna

BNF-referenced

Senna is a natural stimulant laxative derived from the leaves and pods of the Senna plant, primarily used to treat constipation. It works by stimulating bowel movements through irritation of the intestinal lining, which increases peristalsis and enhances the motility of the large intestine. It is commonly employed in both general and palliative care settings.

Indications

  • Constipation
  • Palliative care for bowel cleansing

Dosage

Children: Child 1 month–3 years: 3.75–15 mg once daily, adjusted according to response. Child 4–17 years: 3.75–30 mg once daily, adjusted according to response.

Adults: 7.5–15 mg once daily (max. per dose 30 mg daily), typically taken at bedtime. The initial dose should be low and increased gradually as needed, with higher doses prescribed under medical supervision.

Mechanism of action

Senna contains sennosides, which are metabolized in the colon to form active compounds that stimulate the peristaltic movement of the intestines. This promotes bowel evacuation by increasing the contraction of intestinal muscles and enhancing fluid secretion into the bowel, leading to softer stools.

Pharmacodynamics

The pharmacodynamic effect of senna includes increased intestinal motility and secretion of electrolytes and water into the intestines, resulting in softened stools and facilitation of bowel movements. Side effects may include abdominal cramps and gastrointestinal disturbances, as well as potential skin reactions.

Pharmacokinetics

Senna is not absorbed significantly in the gastrointestinal tract; its active metabolites exert their effects locally in the intestines. The onset of action is typically within 6 to 12 hours when taken orally. Metabolism occurs in the gut, and excretion is primarily via feces, with minimal systemic absorption.

Contra-indications

  • Acute abdominal conditions
  • Acute inflammatory bowel disease
  • Intestinal obstruction
  • Severe dehydration

Adverse effects

  • Abdominal cramps
  • Asthenia
  • Gastrointestinal disorders
  • Skin reactions
  • Urine discolouration

Precautions

  • Excessive use of stimulant laxatives can cause diarrhea and related effects such as hypokalaemia
  • Local irritation - avoid prolonged contact with skin (incontinent patients or infants wearing nappies, risk of irritation and excoriation)
  • Rodent studies indicate potential carcinogenic risk

Pregnancy

Manufacturers advise to avoid - limited information available.

Breast-feeding

Manufacturers advise to avoid - no information available.

Storage

Store at room temperature, away from moisture and heat.

Formulations

  • Oral suspension
  • Tablets
  • Syrup
  • Suppositories
BNF 85 (British National Formulary) p.84 BNF for Children 2019-2020 p.70 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Senna

PubChem CID 73111

Molecular formula: C42H38O20

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.